Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence

Vasc Med. 2018 Dec;23(6):558-559. doi: 10.1177/1358863X18802969. Epub 2018 Sep 21.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angioplasty, Balloon / economics*
  • Angioplasty, Balloon / instrumentation*
  • Angioplasty, Balloon / legislation & jurisprudence
  • Centers for Medicare and Medicaid Services, U.S. / economics*
  • Centers for Medicare and Medicaid Services, U.S. / legislation & jurisprudence
  • Coated Materials, Biocompatible / economics*
  • Evidence-Based Medicine / economics
  • Government Regulation
  • Health Care Costs* / legislation & jurisprudence
  • Humans
  • Peripheral Arterial Disease / diagnosis
  • Peripheral Arterial Disease / economics*
  • Peripheral Arterial Disease / surgery*
  • Policy Making
  • Reimbursement Mechanisms / economics*
  • Reimbursement Mechanisms / legislation & jurisprudence
  • United States
  • Vascular Access Devices* / economics

Substances

  • Coated Materials, Biocompatible